ESRP1 and pancreatic neoplasm: An exception to this pattern has been observed in pancreatic cancer, where ESRP1 acts as a tumor suppressor while miR-23a, which directly targets the 3′UTR of ESRP1, promotes invasion and metastasis of cancer cells [71].